Daratumumab plus len-dex stalls myeloma progression in POLLUX trialJune 15, 2016Multiple MyelomaAggressive Lymphomas
Lenalidomide maintenance prolongs overall survival after ASCTJune 4, 2016Multiple MyelomaCellular Therapy
VIDEO: Adding ixazomib to len-dex boosts progression-free survival in multiple myelomaApril 27, 2016Multiple Myeloma
Bortezomib-based regimen + transplant increased progression-free survival in primary plasma cell leukemiaApril 26, 2016Multiple Myeloma
Daratumumab well tolerated, effective in heavily treated multiple myelomaApril 22, 2016Multiple Myeloma
OTX015 dose for lymphoma narrowed in phase 1 studyApril 10, 2016Indolent LymphomaAggressive LymphomasMultiple Myeloma
